[1] | Atabong, T. A. and Oyesanya, M. O. (2009a). Nonlinear analysis of a fractional reaction diffusion model for tumor invasion, African journal of Mathematics and computer science,3(9) |
[2] | Atabong, T. A. and Oyesanya, M. O. (2009b). Hopf bifurcations in a fractional reaction diffusion model for the invasion and development of tumor, J. of the Nig. Ass. of Math. Phy. 14:267-282 |
[3] | Carmeliet, P. and Jain, R. K. (2000). Angiogenesis in cancer and other disease, Nature. 407: 249-257 |
[4] | Carpinteri A. and Mainardi, F. Fractals and Fractional Calculus in Continuum Mechanics, CISM Courses and Lectures #378, Wien, Springer Verlag: 277-290 (1997) |
[5] | CDC (2004). America Death statistics, Annual statistical report of the Center for Disease Control |
[6] | Chang, W., Crowl, L., Malm, E., Todd-Brown, K., Thomas, L., Vrable, M. Analysing immunotherapy and chemotherapy of tumor through mathematical modeling, Department of Mathematics, Harvey-Mudd University (2003) |
[7] | Cheever, M. A. and Chen, W. (1997). Therapy with cultured T cells: principles revisited, Immunological Reviews, 157:177-194 |
[8] | De Pillis L. and Radunskaya, A. (2001). A mathematical tumor model with immune resistance and drug therapy: an optimal control approach, Journal of Theoretical Medicine, 3:79–100 |
[9] | De Pillis L. and Radunskaya, A. (2003a). The dynamics of an optimally controlled tumor model: A case study, Mathematical and Computer Modeling, 37(11):1221-1244 |
[10] | De Pillis L. and Radunskaya, A. (2003b). A mathematical model of immune response to tumor invasion, In the proceedings of the Second MIT Conference on Computational and Fluid Dynamics, Cambridge:1661-1668 |
[11] | De Pillis, L. and Radunskaya, A. (2003c). A mathematical model of patient-specific response to immunotherapy, Development of Therapeutic Cancer Vaccines (online) |
[12] | De Pillis, L., Radunskaya, A. and Wiseman, C. (2005). A validated mathematical model of cell-mediated immune responses to tumor invasion and vaccine therapy in mice and humans, Cancer Research 61(17):7950-2958 |
[13] | De Pillis, L. Gu, W. and Radunskaya, A. (2006a). Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations, Journal of theoretical biology, 238:841-862 |
[14] | De Pillis, L., and Radunskaya, A. (2006). Chemotherapy for tumors: An analysis of the dynamics and a study of quadratic and linear optimal controls, Mathematical Biosciences, (Accepted) |
[15] | De Pillis, L. G., Mallet D. G. and Radunskaya, A.E. (2006b). Spatial tumor-immune modeling, Computational and mathematical methods in medicine,7(2-3):159-176 |
[16] | De Vries, A., Griebel, J., Kremser, C., Judmaier, W., Gneiting, T., Debbage, P., Kremser, T., Pfeiffer, K.P., Buchberger, W. and Lukas, P. (2000). Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implication for therapy, Radiology, 217: 385–391 |
[17] | De Vries, A., Griebel, J., Kremser, C., Judmaier, W., Gneiting, T., Kreczy, A., Ofner, D., Pfeiffer, K. P., Brix, G. and Lukas, P. (2001). Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma, Cancer Res 61: 2513–2516 |
[18] | Deng, Z., Singh, V.P. and Bengtsson, L. (2004) Numerical solution of fractional advection–dispersion equation, J. Hydraulic Eng., 130:422–431 |
[19] | Devita, V. T., Hellman, S. and Rosenbeng, S. A. (2009), Cancer: Principles and Practice of Oncology, Volume 1 & II, 7th- edition. Philadelphia, J. B. Lippincott Company |
[20] | Elena, D. A. and Jabin, P. E. (2005). Mathematical models of therapeutical actions related to tumor and immune system competition, Mathematical methods in Applied Sc. 28:2061-2083. |
[21] | Gambhir, S. S. (2002). Molecular imaging of cancer with positron emission tomography, Nat Rev Cancer, 2:683-93 |
[22] | Gatenby, R. A. and Gawlinski, E. T. (2003). The glycolytic phenotype in carcinogenesis and tumour invasion: Insight through mathematical models. Cancer Res., 63: 3847-3854 |
[23] | Gatenby,R. A. , Gawlinski, E. T., Arthur, F. G., Brant, K., and Robert, J. G. (2006), Acid-Mediated Tumor Invasion: a multidisplinary study, Cancer Res, 66 (10):5216-5223 |
[24] | Hanahan, D. and Folkman (1996), Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis, Cell, 86: 353-64 |
[25] | Jain, R. K. (1998). The next frontier of molecular medicine: delivery of therapeutics, Nat Med 4: 655–657. |
[26] | Kuby, J. Immunology, third ed., New York, W. H. Freeman and Company (1997) |
[27] | Liu, F., Ahn, V. and Turner, I. (2004). Numerical solution of the space fractional Fokker–Planck equation, J. Comput. Appl. Math. 166:209–219 |
[28] | Lynch, V.E., Carreras, B.A., del-Castillo-Negrete, D., Ferreira-Mejias, K.M. and Hicks, V. (2003). Numerical methods for the solution of partial differential equations of fractional order, J. Comput. Phys., 192:406–421 |
[29] | Meerschaert, M. M. and Tadjeran, C. (2006). Finite difference approximations for two-sided space-fractional partial differential equations, Applied Numerical Mathematics, 56(1):80-90 |
[30] | Meerschaert, M. M., Hans-Peter, S. and Tadjeran, C. (2006). Finite difference method of two dimensional fractional dispersion equations, J. Comput. Physics., 211 (1): 248–261 |
[31] | Meerschaert, M.M. and Tadjeran, C. (2004). Finite difference approximations for fractional advection–dispersion flow equations, J. Comput. Appl. Math., 172 (1): 65–77 |
[32] | Miller, K. S. and Ross, B. An Introduction to the Fractional Calculus and Fractional Differential Equations, New York, Wiley (1993) |
[33] | Oyesanya M. O. and Atabong, T. A. (2008). A Fractional reaction diffusion model for tumor invasion, J. Nig. Math. Soc. 27:159-195 |
[34] | Raghunand, N., Gatenby, R. A., and Gilles, R. J. (2003). Microenvironment and cellular consequences of altered blood flow in tumors, The British Journal of Radiology 76, S11-S22 |
[35] | Rohren E. M. Turkington, T. G. and Coleman R.E. (2004). Clinical application of PET in oncology, Radiology, 231:305-32 |
[36] | Schwerdt, G., Freudinger, R., Schuster, C., Weber, F., Thews, O. and Gekle, M. (2005). Cisplatin-Induced Apoptosis in enhanced by hypoxia and by inhibition of mitochondria in renal collecting Duct cells, Toxicological Science, 85:735-742 |
[37] | Usman, A. , Trachette, J. and Cunningham, C. (2009). Application of the mathematical model for tumor-immune interactions for iL-2 Adoptive Immunotherapy to studies on patients with Metastatic Melanoma or Renal Cell Cancer. (In Press) |